Initially, the target variable was the duration of hospitalization, followed by in-hospital mortality, with the following predictors: tumor stage; grade of differentiation; anatomical location; and the expression status of MLH1, MSH2, MSH6, and PMS2. This evidence concerns the gene MSH6 and neoplasm.